Approval · Notice of Compliance 29665 · 2022
TIMOPTIC-XE: Notice of Compliance 29665
Issued December 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29665
- Date
- December 9, 2022
- Company
- Elvium Life SciencesToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Conversion of the Product Monograph to the Master Template and to update the labels to align with plain language labelling regulations.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIMOPTIC-XE | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per UNIT